Amanda S. Meyer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Amanda S. Meyer has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Ilia A. Droujinine
Scripps Research
3 shared publications - Andrew P. McMahon
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA
2 shared publications David Rocco
Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA
2 shared publicationsDominique K. Carey
Broad Institute of Harvard and MIT, Cambridge, MA, USA
2 shared publicationsJihui Sha
Department of Biological Chemistry, David Geffen School of Medicine University of California Los Angeles California USA
2 shared publicationsJill A. McMahon
Department of Stem Cell Biology and Regenerative Medicine, University of Southern California, Los Angeles, CA, USA
2 shared publications
Latest Publications
- Open Access
- 3 April 2025
- Published by Wiley in Comprehensive Physiology
- Vol. 15 (2) , e70007
Sex and Depot Specific Adipocyte Proteome Profiling In Vivo via Intracellular Proximity Labeling
Adipose tissue has varying distributions and metabolic properties between the sexes. Inherent sex‐specific differences in adipocytes may heighten the risk of metabolic disease in males. Analysis of the adipocyte proteome can potentially provide important insight. To enable cell‐type specific proteomic profiling in vivo, we genetically engineered a mouse line for cell‐type specific production of a promiscuous biotin ligase (BirA*G3) facilitating the rapid isolation of biotinylated cell‐type specific proteomes. Adipocyte‐specific activation of cytoplasmic BirA*G3 led to robust biotinylation of adipocyte proteins across all major fat depots. Comparison of brown adipose tissue (BAT) and subcutaneous white adipose tissue (SAT) proteomes identified 229 brown adipose‐enriched and 35 white adipose‐enriched proteins. Regional comparison of white fat depots revealed additional differences across depots. Comparison of male and female depots identified sexually dimorphic adipose proteins: AHNAK predominating in the male and ACOT2 in the female. These findings validate the genetic model and highlight insights to be gained through targeted profiling of adipocytes. The genetic tool adds to existing approaches for in vivo proximity profiling of cell‐type specific proteome programs.
- 3 April 2025
- Published by Wiley in Comprehensive Physiology
- Vol. 15 (2) , e70007
Open AccessSex and Depot Specific Adipocyte Proteome Profiling In Vivo via Intracellular Proximity Labeling
Adipose tissue has varying distributions and metabolic properties between the sexes. Inherent sex‐specific differences in adipocytes may heighten the risk of metabolic disease in males. Analysis of the adipocyte proteome can potentially provide important insight. To enable cell‐type specific proteomic profiling in vivo, we genetically engineered a mouse line for cell‐type specific production of a promiscuous biotin ligase (BirA*G3) facilitating the rapid isolation of biotinylated cell‐type specific proteomes. Adipocyte‐specific activation of cytoplasmic BirA*G3 led to robust biotinylation of adipocyte proteins across all major fat depots. Comparison of brown adipose tissue (BAT) and subcutaneous white adipose tissue (SAT) proteomes identified 229 brown adipose‐enriched and 35 white adipose‐enriched proteins. Regional comparison of white fat depots revealed additional differences across depots. Comparison of male and female depots identified sexually dimorphic adipose proteins: AHNAK predominating in the male and ACOT2 in the female. These findings validate the genetic model and highlight insights to be gained through targeted profiling of adipocytes. The genetic tool adds to existing approaches for in vivo proximity profiling of cell‐type specific proteome programs.
- Open Access
- 10 August 2022
- Published by The Royal Society in Open Biology
- Vol. 12 (8) , 220149
A genetic model for in vivo proximity labelling of the mammalian secretome
Organ functions are highly specialized and interdependent. Secreted factors regulate organ development and mediate homeostasis through serum trafficking and inter-organ communication. Enzyme-catalysed proximity labelling enables the identification of proteins within a specific cellular compartment. Here, we report a BirA*G3 mouse strain that enables CRE-dependent promiscuous biotinylation of proteins trafficking through the endoplasmic reticulum. When broadly activated throughout the mouse, widespread labelling of proteins was observed within the secretory pathway. Streptavidin affinity purification and peptide mapping by quantitative mass spectrometry (MS) proteomics revealed organ-specific secretory profiles and serum trafficking. As expected, secretory proteomes were highly enriched for signal peptide-containing proteins, highlighting both conventional and non-conventional secretory processes, and ectodomain shedding. Lower-abundance proteins with hormone-like properties were recovered and validated using orthogonal approaches. Hepatocyte-specific activation of BirA*G3 highlighted liver-specific biotinylated secretome profiles. The BirA*G3 mouse model demonstrates enhanced labelling efficiency and tissue specificity over viral transduction approaches and will facilitate a deeper understanding of secretory protein interplay in development, and in healthy and diseased adult states.
- 10 August 2022
- Published by The Royal Society in Open Biology
- Vol. 12 (8) , 220149
Open AccessA genetic model for in vivo proximity labelling of the mammalian secretome
Organ functions are highly specialized and interdependent. Secreted factors regulate organ development and mediate homeostasis through serum trafficking and inter-organ communication. Enzyme-catalysed proximity labelling enables the identification of proteins within a specific cellular compartment. Here, we report a BirA*G3 mouse strain that enables CRE-dependent promiscuous biotinylation of proteins trafficking through the endoplasmic reticulum. When broadly activated throughout the mouse, widespread labelling of proteins was observed within the secretory pathway. Streptavidin affinity purification and peptide mapping by quantitative mass spectrometry (MS) proteomics revealed organ-specific secretory profiles and serum trafficking. As expected, secretory proteomes were highly enriched for signal peptide-containing proteins, highlighting both conventional and non-conventional secretory processes, and ectodomain shedding. Lower-abundance proteins with hormone-like properties were recovered and validated using orthogonal approaches. Hepatocyte-specific activation of BirA*G3 highlighted liver-specific biotinylated secretome profiles. The BirA*G3 mouse model demonstrates enhanced labelling efficiency and tissue specificity over viral transduction approaches and will facilitate a deeper understanding of secretory protein interplay in development, and in healthy and diseased adult states.
- Open Access
- 22 April 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-22
Proteomics of protein trafficking by in vivo tissue-specific labeling
Conventional approaches to identify secreted factors that regulate homeostasis are limited in their abilities to identify the tissues/cells of origin and destination. We established a platform to identify secreted protein trafficking between organs using an engineered biotin ligase (BirA*G3) that biotinylates, promiscuously, proteins in a subcellular compartment of one tissue. Subsequently, biotinylated proteins are affinity-enriched and identified from distal organs using quantitative mass spectrometry. Applying this approach in Drosophila, we identify 51 muscle-secreted proteins from heads and 269 fat body-secreted proteins from legs/muscles, including CG2145 (human ortholog ENDOU) that binds directly to muscles and promotes activity. In addition, in mice, we identify 291 serum proteins secreted from conditional BirA*G3 embryo stem cell-derived teratomas, including low-abundance proteins with hormonal properties. Our findings indicate that the communication network of secreted proteins is vast. This approach has broad potential across different model systems to identify cell-specific secretomes and mediators of interorgan communication in health or disease.
- 22 April 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-22
Open AccessProteomics of protein trafficking by in vivo tissue-specific labeling
Conventional approaches to identify secreted factors that regulate homeostasis are limited in their abilities to identify the tissues/cells of origin and destination. We established a platform to identify secreted protein trafficking between organs using an engineered biotin ligase (BirA*G3) that biotinylates, promiscuously, proteins in a subcellular compartment of one tissue. Subsequently, biotinylated proteins are affinity-enriched and identified from distal organs using quantitative mass spectrometry. Applying this approach in Drosophila, we identify 51 muscle-secreted proteins from heads and 269 fat body-secreted proteins from legs/muscles, including CG2145 (human ortholog ENDOU) that binds directly to muscles and promotes activity. In addition, in mice, we identify 291 serum proteins secreted from conditional BirA*G3 embryo stem cell-derived teratomas, including low-abundance proteins with hormonal properties. Our findings indicate that the communication network of secreted proteins is vast. This approach has broad potential across different model systems to identify cell-specific secretomes and mediators of interorgan communication in health or disease.